EUS elastography for the differentiation of benign and malignant lymph nodes: a meta-analysis
Background EUS elastography is a new technique for differentiating benign and malignant lymph nodes (LNs) by describing the mechanical property of the target tissue. Objective To assess the accuracy of EUS elastography by pooling data of existing trials. Design Seven studies involving 368 patients w...
Gespeichert in:
Veröffentlicht in: | Gastrointestinal endoscopy 2011-11, Vol.74 (5), p.1001-1009 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background EUS elastography is a new technique for differentiating benign and malignant lymph nodes (LNs) by describing the mechanical property of the target tissue. Objective To assess the accuracy of EUS elastography by pooling data of existing trials. Design Seven studies involving 368 patients with 431 LNs were included. Meta-analysis was performed. Pooling was conducted in a fixed-effect model or a random-effect model. Patients This study involved 368 patients. Intervention EUS elastography. Main Outcome Measurements Meta-analysis and meta-regression analysis. Results The pooled sensitivity of EUS elastography for the differential diagnosis of benign and malignant LNs was 88% (95% confidence interval [CI] 0.83-0.92), and the specificity was 85% (95% CI, 0.79-0.89). The area under the curve under summary receiver operating characteristic (SROC) was 0.9456. The pooled positive likelihood ratio was 5.68 (95% CI, 2.86-11.28), and the negative likelihood ratio was 0.15 (95% CI, 0.10-0.21). The subgroup analysis by excluding the outliers provided a sensitivity of 85% (95% CI, 0.79-0.90) and a specificity of 91% (95% CI, 0.85-0.95) for the differential diagnosis of benign and malignant LNs. The area under the curve under SROC was 0.9421. Limitations A small number of studies met inclusion criteria. Conclusion EUS elastography is a promising, noninvasive method for differential diagnosis of malignant LNs and may prove to be a valuable supplemental method to EUS-guided FNA. |
---|---|
ISSN: | 0016-5107 1097-6779 |
DOI: | 10.1016/j.gie.2011.07.026 |